BNGO vs CLOV · rev $30.8M vs rev $1.37B
Bionano Genomics Inc (BNGO) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Bionano Genomics Inc (BNGO) is a medical instruments & supplies company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BNGO revenue for 2024-12-31 was $30.8M. Net income was -$112.0M. Revenue was down 14.8% from 2023-12-31 to 2024-12-31. BNGO currently screens at market cap $13.4M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BNGO currently screens at market cap $13.4M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BNGO and CLOV stock pages for the full models.
Not investment advice.